- Investing Ideas
- Australian Pharmaceuticals & Biotech Pure Equity Growth
Australian Pharmaceuticals & Biotech Pure Equity Growth
Results
2
0 new
Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.
2 companies
Neuren Pharmaceuticals
Market Cap: AU$2.2b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$17.54
7D
4.8%
1Y
18.8%
Neuren Pharmaceuticals
Market Cap: AU$2.2b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$17.43
7D
4.3%
1Y
18.2%